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Dissecting Suicidality
Using a Combined
Genomic and Clinical
Approach
‘Never give in, never give in, never,
never, never.’
– Winston Churchill
One person dies by suicide every 40 s
worldwide, despite suicide being a
potentially preventable tragedy. It is
clear that better assessment, tracking,
and prediction of suicidality (ideation,
actions) are needed. We endeavored to
develop better clinical data tools and
objective blood biomarkers for such
purposes. The two approaches are
complementary, synergistic, and can
inform each other.
First, in terms of clinical data, we
developed a simple polyphenic risk
score, based on phenes (phenotypic
items) that are known risk factors for
suicide. Similar to polygenic scoring,
these were scored in a binary fashion
as 0 or 1 (absent or present). This
questionnaire/app, known as Conver-
gent Functional Information for Sui-
cide (CFI-S), has 22 easy-to-answer
items, related to life issues, mental
health, physical health, environmental
stress, addictions, and cultural factors.
It purposefully does not ask about
suicidal ideation, as that is a loaded
question in most settings, and because
people who truly want to kill them-
selves may not share that information
for fear of being stopped. CFI-S can be
self-scored or clinician scored, ob-
tained from patient interview, or from
information from next of kin or
medical records. CFI-S has shown
good predictive ability for suicidal
ideation and for future hospitalizations
for suicidality, in men (Niculescu et al,
2015) and in women (Levey et al,
2016). It can have a therapy-guiding
component, in that over half of the risk
factors it identifies are correctable. In
addition, we have developed and used
a simple visual analog scale type of
questionnaire/app, known as Simple
Affective State Scale (SASS), that pro-
vides a score for anxiety and one for
mood at a particular moment in time
(Niculescu et al, 2015; Levey et al,
2016). High anxiety scores and low
mood scores were predictive for suici-
dal ideation and future hospitalizations
by themselves, and even more so when
combined with the CFI-S score,
which provides broader contextual
information.
Second, as the brain (the target
organ) cannot be biopsied in live
individuals, we endeavored to develop
a liquid biopsy, ie, to find blood
biomarkers for suicidality that would
have translational and practical clinical
utility. The possibility of finding blood
biomarkers for psychiatric phenotypes
had been substantiated by earlier pilot
studies by our group focused on mood
(Le-Niculescu et al, 2009), psychosis
(Kurian et al, 2011), and suicide
(Le-Niculescu et al, 2013). How and
why peripheral molecular changes
reflect what is happening in the brain
is an area of ongoing research. Brain
cells and blood cells share some genetic
polymorphisms, as well as exposure to
the internal milieu and whole-body
responses such as stress. There are also
more direct neuro-immune connec-
tions. However, it is likely that only a
small proportion of peripheral changes
in gene expression are relevant to and/
or concordant with brain changes
related to suicide. Finding the true
signal among all the noise is key to
success. It is predicated on having, for
example, a powerful longitudinal
within-subject design to conduct the
discovery, prioritization of findings
using convergent functional genomics,
and validation of the biomarkers in
relevant independent cohorts
(Niculescu et al, 2015). Using such
approaches, we were successful in
finding blood biomarkers that were
predictive of suicidality, at least in the
psychiatric patient populations that we
have studied so far (Niculescu et al,
2015; Levey et al, 2016; Le-Niculescu
et al, 2013). Some of them have prior
brain gene expression evidence
(Niculescu et al, 2015; Levey et al,
2016), which is part of our convergent
approach to prioritize them. While the
biomarkers were reasonably predictive
by themselves, they were in general less
predictive than the clinical information
scores we described above. The bio-
markers may serve a useful purpose
when clinical information is not avail-
able and/or to (1) provide a window
into the biology of suicidality, (2) help
stratify patients, and (3) monitor dis-
ease course and response to treatment
in an objective fashion. Importantly,
when combined, the biomarker scores
and clinical information scores were
synergistic in terms of improved pre-
dictive ability (Niculescu et al, 2015;
Levey et al, 2016).
It has not escaped our attention that
the general strategy outlined here can be
used to try to understand, predict, and
improve other behavioral phenotypes.
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Food Addiction and
Obesity
The obesity epidemic in the US and
abroad has increased interest in neu-
robiological mechanisms that contri-
bute to eating in the absence of energy
demand or hunger (overeating).
Overeating, sometimes called ‘hedonic’
feeding because foods consumed are
usually palatable and high in sugars
and fats, is the leading cause of
overweight and obesity in the US.
One important factor that contributes
to obesity is overeating triggered by
sights, sounds, and smells (food cues)
associated with palatable food (Stice
et al, 2013; Tang et al, 2012). For
example, obese and overweight people
report greater food craving and
consume larger portions in response
to food cues. A wealth of preclinical
studies have demonstrated that these
cue-triggered motivational responses
are mediated by brain mesocorticolim-
bic circuits, particularly dopamine and
glutamate transmission within the
nucleus accumbens (NAc). In humans,
the magnitude of activations in the
NAc in response to food cues predicts
future weight gain in normal-weight
people and inability to lose weight after
obesity onset. This suggests that
differences in NAc function may
mediate enhanced cue-triggered urges
to eat in susceptible individuals both
before and after weight gain. The
overlap in the neural systems involved
and similarities between responses to
food, addictive drugs, and cues
associated with them have sparked
vibrant discussion about ‘food addic-
tion’ (Carter et al, 2016), despite some
obvious differences between food and
drug (eg, food does not have psychoac-
tive properties in the pharmacological
sense, nor is there a clear dose-
response relationship, etc.). So, can
overeating that produces common
obesity really be considered a form of
addiction?
In a recent preclinical study we
found that, prior to any diet manipula-
tion, those rats that show the strongest
motivational responses to a food cue
subsequently gained the most weight
when given free access to a fatty,
sugary, ‘junk-food’ diet (Robinson
et al, 2015). Obesity-prone rats are also
more sensitive to the locomotor-
activating effects of cocaine, indicating
enhanced responsivity of mesolimbic
systems, and have greater excitability
of medium spiny neurons in the NAc
core prior to the development of
obesity (Oginsky et al, 2016a, b). Taken
together, our data suggest that pre-
existing enhancements in NAc respon-
sivity may render obesity-susceptible
individuals more sensitive to the mo-
tivational properties of food cues. In
addition, consumption of fatty, sugary
foods alters NAc function in ways that
also vary by susceptibility to obesity.
For example, consumption of junk food
enhances NAc glutamatergic transmis-
sion and produces an upregulation of
calcium-permeable AMPA receptors
(CP-AMPARs) in obesity-susceptible
rats (Brown et al, 2015; Oginsky et al,
2016a). Interestingly, increases in CP-
AMPARs were found prior to obesity
onset, suggesting that they may drive
enhanced motivational responses that
promote weight gain (see Oginsky et al,
2016b for further discussion).
Enhanced cue triggered motivation
and accompanying increases in NAc
responsivity are thought to underlie
drug addiction (Flagel et al, 2009),
and NAc CP-AMPARs mediate
enhanced cue-trigged cocaine-seeking
(Wolf, 2016). One pressing question
that arises, however, is the extent to
which the enhanced neurobehavioral
responsivity found in obesity-
susceptible rats is a form of aberrant
motivation, akin to drug addiction.
Brain reward circuits evolved in part
to direct behavior towards food.
Thus, enhancements in NAc respon-
sivity and cue-triggered motivation
could be described as an improved
function of this system (ie, rendering
individuals better able to find food)
rather than dysfunction. Of course,
not being able to curb cue-triggered
urges in the current calorie-dense food
environment is unhealthy, and it is not
entirely clear where this idea leaves
obesity-resistant individuals. Are they
the outliers? However, to develop
better prevention strategies for obesity
it will be important to differentiate
‘normal’ neurobehavioral responses
from fundamentally aberrant ones
and to continue to challenge ourselves
by asking these questions.
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